StockData
RadNet, Inc. logo

RadNet, Inc. (RDNT) stock

RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3041% above fair value
$78.08+0.14 (+0.18%)

Close on Nov 11, 2026Market cap $6.14BP/E –Yield –

RadNet, Inc. grew revenue 21.1% to $2.38B over the twelve months to Sep 30, 2026. Operating income rose 25.5% to $73.65M, moving the operating margin from 3.0% to 3.1%. At the latest close the market valued the company at $6.14B.

Revenue
$2.38B
+21.1% vs. a year earlier
Operating income
$73.65M
+25.5% vs. a year earlier
EPS, diluted
-$0.29
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$6.14B
P/E ratio
–
Price to sales
2.58
Price to book
5.48
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$2.38B
Net income
-$22.38M
EPS, diluted
-$0.29
Book value per share
$14.16
Diluted shares
79M

Trading

Next earnings
Mar 1, 2027 (estimated, before the open)
Previous close
$77.94
Open
$79.03
Day's range
$77.83 – $79.96
Volume
732,338
Average volume (20 days)
751,583
Index membership
S&P SmallCap 600 (since Nov 2019), Russell 2000, Russell 3000
Beta (5 years)
1.16
52-week range
$50.82 – $85.84
RSI (14 days)
61.7
Volatility (1 year)
43.1%
Relative volume
1.03×
WACC
9.4%

Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2010, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodRDNTS&P 500DifferenceRDNT per yearS&P 500 per year
1 month+10.1%-2.4%+12.5 pts
3 months+2.3%-1.2%+3.4 pts
Year to date+9.4%+12.3%−2.9 pts
1 year-0.5%+12.4%−13.0 pts
3 years+167.6%+78.8%+88.8 pts+38.8%+21.4%
5 years+146.8%+75.2%+71.6 pts+19.8%+11.9%
10 years+1048.2%+311.1%+737.1 pts+27.6%+15.2%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$2.38B+21.1% YoY

Gross profit

–

Operating income

$73.65M+25.5% YoY

Net income

-$22.38M

EPS, diluted

-$0.29

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases RadNet filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About RadNet

Services-Medical Laboratories

RadNet provides diagnostic imaging services and digital healthcare solutions. The company operates through two primary business segments: Imaging Centers and Digital Health. Its core offerings include outpatient diagnostic imaging services, healthcare management services, medical software development, and specialized radiology technologies. RadNet serves patients, medical practices, and healthcare facilities. Its customer base and reimbursement sources comprise commercial health insurance providers, government programs such as Medicare and Medicaid, workers' compensation plans, and individuals covered under capitation and personal injury arrangements.

Company profile, executives and history

RadNet stock: common questions

What is RadNet's stock price?

RDNT closed at $78.08 on Nov 11, 2026, up 0.18% on the day. Over the past 52 weeks it traded between $50.82 and $85.84.

What is RadNet's market cap?

RadNet was worth $6.14B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is RDNT's P/E ratio?

RadNet lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.29), so it has no meaningful P/E ratio.

How much revenue does RadNet make?

RadNet reported revenue of $2.38B for the twelve months to Sep 30, 2026, up 21.1% from a year earlier.

Does RadNet pay a dividend?

No. RadNet has not paid a cash dividend over the last twelve months.

When does RadNet report earnings next?

RadNet is expected to report Q4 FY2026 results on Mar 1, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has RDNT stock performed over the past year?

Including dividends, RDNT returned -0.5% over the past year, against +12.4% for the S&P 500.

How many RDNT shares are sold short?

9M shares were sold short at the latest FINRA report, 11.83% of the float, or 18.0 days of average trading volume.

Who are RadNet's competitors?

Companies most similar to RadNet by business, industry and size include NTRA, DGX, FLGT, FTRE, GH.

See a number that looks wrong?